By upregulating serum IgA, IgG and IgM levels, enlarging the population of CD4+ T cells and balancing the ratio of CD4+/CD8+ cells, HQH significantly lowered the rate of reinfection in severe pediatric patients of Mycoplasma pneumonia (13). This evidence concerns the gene CD4 and Mycoplasma pneumoniae pneumonia.